Immunogenic Material Vaccine for Cancer Immunotherapy by Structure‐Dependent Immune Cell Trafficking and Modulation
Advanced Materials · 2024
DOI: 10.1002/adma.202402580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Wei Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200092, P. R. China. Hauptthemen laut MEDLINE: Cancer Vaccines, Immunotherapy, Dendritic Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Clinical Research Plan of SHDC.
Abstract (Originalsprache)
Inherently immunogenic materials offer enormous prospects in enhancing vaccine efficacy. However, the understanding and improving material adjuvanticity remain elusive. Herein how the structural presentation of immunopotentiators in a material governs the dynamic dialogue between innate and adaptive immunity for enhanced cancer vaccination is reported. The immunopotentiator manganese into six differing structures that resemble the architectures of two types of pathogens (spherical viruses or rod‐like bacteria) is precisely manipulated. The results reveal that innate immune cells accurately sense and respond to the architectures, of which two outperformed material candidates (151 nm hollow spheres and hollow microrods with an aspect ratio of 4.5) show higher competence in creating local proinflammatory environment with promoted innate immune cell influx and stimulation on dendritic cells (DCs). In combination with viral peptides, model proteins, or cell lysate antigens, the outperformed microrod material remarkably primes antigen‐specific CD8 cytolytic T cells. In prophylactic and therapeutic regimens, the microrod adjuvanted vaccines display optimal aptitude in tumor suppression in four aggressive murine tumor models, by promoting the infiltration of heterogeneous cytolytic effector cells while decreasing suppressive immunoregulatory populations in tumors. This study demonstrates that a rationally selected architecture of immunogenic materials potentially advances the clinical reality of cancer vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200092, P. R. China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou Institute of Shanghai University, Wenzhou, Zhejiang, 325088, P. R. China.
- Shanghai Institute of Materdicine, Shanghai, 200051, P. R. China.
ORCID-Profile: Yu Chen
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Clinical Research Plan of SHDC
- Shanghai Municipal Health Commission
- Natural Science Foundation of Shanghai
- School of Medicine, Shanghai Jiao Tong University
- Shanghai Pujiang Program
- Wenzhou Basic Scientific Research Project
Zitieren
APA
Yang, W., Cao, J., Di, S., Chen, W., Cheng, H., Ren, H., Xie, Y., Chen, L., Yu, M., Chen, Y., & Cui, X. (2024). Immunogenic Material Vaccine for Cancer Immunotherapy by Structure‐Dependent Immune Cell Trafficking and Modulation. Advanced Materials. https://doi.org/10.1002/adma.202402580
Vancouver
Yang W, Cao J, Di S, Chen W, Cheng H, Ren H, et al. Immunogenic Material Vaccine for Cancer Immunotherapy by Structure‐Dependent Immune Cell Trafficking and Modulation. Advanced Materials. 2024. doi:10.1002/adma.202402580
BibTeX
@article{Yang2024,
author = {Yang, Wei and Cao, Jianwei and Di, Sichen and Chen, Wenjin and Cheng, Hui and Ren, Hongze and Xie, Yujie and Chen, Liang and Yu, Meihua and Chen, Yu and Cui, Xingang},
title = {Immunogenic Material Vaccine for Cancer Immunotherapy by Structure‐Dependent Immune Cell Trafficking and Modulation},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202402580}
}
EUVIMED